by Alison Bass | Jan 18, 2012 | antipsychotic drugs, conflicts of interest, drug marketing, expert testimony, media coverage, pharmaceutical industry, whistleblowing
Allen Jones, the whistleblower in an ongoing landmark trial against the pharmaceutical giant Johnson & Johnson, was very much on my mind this past weekend. I was participating in a workshop to develop curriculum to teach college students about the importance of...
by Alison Bass | Jun 8, 2011 | antidepressants, conflicts of interest, expert testimony, medical devices, National Institutes of Health
A few weeks ago, I blogged about the strange case of Dr. Helen Mayberg, a neurologist at Emory University who has testified in more death penalty cases in recent years than almost any other doctor in the country. I highlighted Mayberg’s lucrative and lethal (she...
by Alison Bass | May 17, 2011 | conflicts of interest, expert testimony, medical devices, National Institutes of Health, patient care
A year ago, the Department of Health and Human Services proposed new rules governing the disclosure and handling of financial conflicts of interest by medical researchers who receive federal funding. The more stringent rules were prompted by Congressional findings...
